Many patients whose tumours express EGFR fail to respond to EGFR targeted therapy, and conversely, patients who respond may have tumours that do not exhibit EGFR expression (Noberasco et al, 2005; Younes, 2005). This evidence concerns the gene EGFR and neoplasm.